+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria



Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria



Clinical Microbiology and Infection 15(10): 919-923



The aim of this study was to determine the frequency of erm genes coding for macrolide resistance among clinical isolates of non-pigmented rapidly growing mycobacteria (NPRGM) and to evaluate their importance in phenotypic resistance. Broth microdilution susceptibility testing was performed for all NPRGM tested. A PCR assay with consensus primers was used to evaluate the presence of erm genes among the 167 clinical isolates studied, which belonged to nine species of NPRGM; erm genes were detected in all nine species and 109 strains were erm-positive. The highest percentage of erm-positive isolates was found among Mycobacterium mageritense (100%) and the lowest among Mycobacterium mucogenicum (14%). The MICs of macrolides were found to be lower for erm-negative isolates (MIC(90): 2 mg/L) than for erm-positive isolates (MIC(90): 16 mg/L), although in some cases high MICs were found for erm-negative isolates. The finding that erm methylases are present in the majority of the species of NPRGM analysed in this study is not in agreement with conventional susceptibility studies. It therefore appears necessary to use a combination therapy to treat infections caused by NPRGM.

(PDF emailed within 0-6 h: $19.90)

Accession: 055157622

Download citation: RISBibTeXText

PMID: 19438639

DOI: 10.1111/j.1469-0691.2009.02757.x


Related references

Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria. International Journal of Antimicrobial Agents 34(5): 454-456, 2009

Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clinical Microbiology and Infection 15(10): 931-936, 2009

Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital. Journal of Infection 54(2): 135-145, 2006

Polyclonality among clinical strains of non-pigmented rapidly growing mycobacteria: phenotypic and genotypic differences and their potential implications. Clinical Microbiology and Infection 21(4): 348.E1-4, 2016

Mercuric reductase hgre activity in clinical isolates of rapidly growing mycobacteria rgm. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 135, 1988

Prevalence of β-lactamase and 16S rRNA methylase genes among clinical Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from animals. Microbial Drug Resistance 19(3): 237-245, 2013

In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrobial Agents and ChemoTherapy 51(5): 1849-1851, 2007

Mercuric reductase activity and evidence of broad-spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria. Antimicrobial Agents and ChemoTherapy 35(5): 819-823, 1991

Prevalence of 16S rRNA methylase genes among β-lactamase-producing Enterobacteriaceae clinical isolates in Saudi Arabia. Libyan Journal of Medicine 9(): 24432-24432, 2014

Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria. Bmc Microbiology 8(): 184-184, 2008

In-vitro evaluation of the adhesion to polypropylene sutures of non-pigmented, rapidly growing mycobacteria. Clinical Microbiology and Infection 13(9): 902-907, 2007

Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria. International Journal of Antimicrobial Agents 32(4): 366-367, 2008

In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine. Australian Veterinary Journal 93(1-2): 40-45, 2015

Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. International Journal of Antimicrobial Agents 37(4): 352-355, 2011

Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. International Journal of Antimicrobial Agents 38(4): 348-351, 2012